Related references
Note: Only part of the references are listed.Discovery of potent 4-aminoquinoline hydrazone inhibitors of NRH:quinoneoxidoreductase-2 (NQO2)
Buthaina Hussein et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Facile construction of fused benzimidazole-isoquinolinones that induce cell-cycle arrest and apoptosis in colorectal cancer cells
Liu-Jun He et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Evaluation of analogues of furan-amidines as inhibitors of NQO2
Soraya Alnabulsi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Application of Berendsen barostat in dissipative particle dynamics for nonequilibrium dynamic simulation
Yuqing Lin et al.
JOURNAL OF CHEMICAL PHYSICS (2017)
[1,2]Oxazolo[5,4-e]isoindoles as promising tubulin polymerization inhibitors
Virginia Spano et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
The anti-angiogenic effect and novel mechanisms of action of Combretastatin A-4
Min Su et al.
SCIENTIFIC REPORTS (2016)
Long-Time-Step Molecular Dynamics through Hydrogen Mass Repartitioning
Chad W. Hopkins et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2015)
ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB
James A. Maier et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2015)
Synthesis and biological evaluation of 2,3-diaryl isoquinolinone derivatives as anti-breast cancer agents targeting ERα and VEGFR-2
Zhichao Tang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Endothelial Cell Tube Formation Assay for the In Vitro Study of Angiogenesis
Katie L. DeCicco-Skinner et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2014)
Synthesis and Antiproliferative Activity of the Ring System [1,2]Oxazolo[4,5-g]indole
Paola Barraja et al.
CHEMMEDCHEM (2012)
In Silico Screening Reveals Structurally Diverse, Nanomolar Inhibitors of NQO2 That Are Functionally Active in Cells and Can Modulate NF-kappa B Signaling
Karen A. Nolan et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Synthesis of 12-oxobenzo[c]phenanthridinones and 4-substituted 3-arylisoquinolones via Vilsmeier-Haack reaction
Daulat Bikram Khadka et al.
TETRAHEDRON (2012)
Indolequinone Inhibitors of NRH:Quinone Oxidoreductase 2. Characterization of the Mechanism of Inhibition in both Cell-Free and Cellular Systems
Chao Yan et al.
BIOCHEMISTRY (2011)
Principles of early drug discovery
J. P. Hughes et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Eribulin Induces Irreversible Mitotic Blockade: Implications of Cell-Based Pharmacodynamics for In vivo Efficacy under Intermittent Dosing Conditions
Murray J. Towle et al.
CANCER RESEARCH (2011)
Mechanism-Based Inhibition of Quinone Reductase 2 (NQO2): Selectivity for NQO2 over NQO1 and Structural Basis for Flavoprotein Inhibition
Marine Dufour et al.
CHEMBIOCHEM (2011)
Novel Inhibitors of NRH:Quinone Oxidoreductase 2 (NQO2): Crystal Structures, Biochemical Activity, and Intracellular Effects of Imidazoacridin-6-ones
Mark S. Dunstan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Combretastatin A4 phosphate: a novel vascular disrupting agent
Govardhanan Nagaiah et al.
FUTURE ONCOLOGY (2010)
Anti-angiogenic and vascular disrupting effects of C9, a new microtubule-depolymerizing agent
Xuan Ren et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Pyrrolotetrazinones deazaanalogues of temozolomide induce apoptosis in Jurkat cell line: involvement of tubulin polymerization inhibition
Giampietro Viola et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Antivascular Actions of Microtubule-Binding Drugs
Edward L. Schwartz
CLINICAL CANCER RESEARCH (2009)
Langevin thermostat for rigid body dynamics
Ruslan L. Davidchack et al.
JOURNAL OF CHEMICAL PHYSICS (2009)
Vascular Disrupting Activity of Tubulin-Binding 1,5-Diaryl-1H-imidazoles
Katiuscia Bonezzi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Asymmetric synthesis of 2,3-dihydro-2-arylquinazolin-4-ones: Methodology and application to a potent fluorescent tubulin inhibitor with anticancer activity
Gary M. Chinigo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Flavin-dependent quinone reductases
S. Deller et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Novel imidazole-based combretastatin A-4 analogues: Evaluation of their in vitro antitumor activity and molecular modeling study of their binding to the colchicine site of tubulin
Fabio Bellina et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Microtubule-targeting agents inhibit angiogenesis at subtoxic concentrations, a process associated with inhibition of Rac1 and Cdc42 activity and changes in the endothelial cytoskeleton
Marcel N. A. Bijman et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Microtubule-targeting agents in angiogenesis:: Where do we stand?
Eddy Pasquier et al.
DRUG RESISTANCE UPDATES (2006)
Sulforhodamine B colorimetric assay for cytotoxicity screening
Vanicha Vichai et al.
NATURE PROTOCOLS (2006)
Clonogenic assay of cells in vitro
Nicolaas A. P. Franken et al.
NATURE PROTOCOLS (2006)
The Amber biomolecular simulation programs
DA Case et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)
Metabolism and bioavailability of trans-resveratrol
E Wenzel et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2005)
Microtubules as a target for anticancer drugs
MA Jordan et al.
NATURE REVIEWS CANCER (2004)
Crystal structure of quinone reductase 2 in complex with resveratrol
L Buryanovskyy et al.
BIOCHEMISTRY (2004)
Deficiency of NRH:quinone oxidoreductase 2 increases susceptibility to 7,12-dimethylbenz(a)anthracene and benzo(a)pyrene-induced skin carcinogenesis
K Iskander et al.
CANCER RESEARCH (2004)
Development and testing of a general amber force field
JM Wang et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
High absorption but very low bioavailability of oral resveratrol in humans
T Walle et al.
DRUG METABOLISM AND DISPOSITION (2004)
Development of polyphosphate parameters for use with the AMBER force field
KL Meagher et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2003)
Disruption of dihydronicotinamide riboside:quinone oxidoreductase 2 (NQO2) leads to myeloid hyperplasia of bone marrow and decreased sensitivity to menadione toxicity
DJ Long et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Structure-activity relationship studies of isoquinolinone type anticancer agent
SH Cheon et al.
ARCHIVES OF PHARMACAL RESEARCH (2001)
Share Paper
